60. アルブミン投与によるsymptomatic vasospasmの予防
スポンサーリンク
概要
- 論文の詳細を見る
We reported that the hyperdynamic therapy by the administration of a large amount of albumin was markedly effective for the treatment of symptomatic vasospasm with SAH caused by ruptured aneurysm. Based upon this results, we have attempted to use albumin prophylactically for the prevention of symptomatic vasospasm and obtained an excellent results. <BR>In this report, we are reporting the results of this treatment, the amount and duration of albumin administration that we have used. <BR>During the past two years, twenty five patients who belonged to the Group 3 CT classification of SAH reported by Fisher, in which have a possibility to develop 98% of symptomatic vasospasm, were the subject of this study. Eighteen patients out of 25 underwent an early operation of clipping aneurysm with the evacuation of subarachnoid blood clot and cisternal drainage. In 7 patients out of 25, surgery was intensively delayed by various reasons. After the confirmative CT scan for the diagnosis of SAH in Group 3, albumin 1-2 gm/kg/day were administered venously for 7-14 days in those 25 cases for the prevention of symptomatic vasospasm. Only three patients (16.7%) out of 18 who underwent early operation developed sympathetic vasospasm. Among seven patients whose operations were intentionally delayed, three patients (42.8%) developed symptomatic vasospasm. <BR>Thus, the overall results were only 6 patients (24%) out of 25 developed symptomatic vasospasm. This was a very low incidence of symptomatic vasospasm compared with that of Fisher's report (98%). Analysis of the amount of albumin administration revealed that 1.0±0.3gm/kg/day in symptomatic vasospasm patients, and 1.25±0.3gm/kg/day in non-symptomatic patients. There was a statistically significant difference among those two groups. Five patients out of 6 in symptomatic vasospasm group did developed the neurological manifestations during the gradual decreasing period of albumin administration, 4-9 days after the beginning of this treatment with initial amount of 1.0 gm/kg/day of albumin administration. <BR>It can be speculated that it may be possible to decrease the incidence of symptomatic vasospasm by the adequate amount of albumin administration even in the state of severe SAH during the waiting time for the surgery of the ruptured aneurysm. Moreover the symptomatic vasospasm may be able to be prevented, if the early operation of the clipping of aneurysm were performed with the extensive evacuation of subarachnoid blood clot and cisternal drainage followed by the postoperative hyperdynamic therapy using adequate amount of albumin administration.
- The Japanese Society on Surgery for Cerebral Strokeの論文
著者
-
遠藤 昌孝
北里大学脳神経外科
-
矢田 賢三
北里大学脳神経外科学
-
高木 宏
北里大学脳神経外科
-
斎藤 武志
北里大学脳神経外科
-
田辺 貴丸
北里大学脳神経外科
-
酒井 英光
北里大学脳神経外科
-
矢田 賢三
北里大学脳神経外科
関連論文
- 小型の未破裂脳動脈瘤に外科的治療は必要か?
- リン酸カルシウムの生体中における結晶成長 : Part2 生体分子の結晶成長
- 三叉神経痛を示した脳幹部AVMに対する摘出術
- 水頭症shunt手術の希有なる合併症 : 髄液の脳実質内進展
- 硬膜下新生膜に出現する平滑筋細胞とmyofibroblastの起源とその意義について
- 人為的低血圧の中枢神経組織に与える影響についての研究 : -第1報,脳微小循環の形態学的研究-
- 脳動脈奇形例における"silent"hemorrhageの臨床病床病理学的検討とその臨床的意義
- 側脳室脈絡叢部のsmall vascular malformation : 臨床診断上の問題点について
- 脳動脈瘤,術後頭蓋内圧の経時的推移の検討
- CT scanにて診断した両側性高血圧性脳出血 : 5症例の報告と文献的考察
- 前屈位脊髄症の病態と治療
- 2.外傷性脳血管障害
- 松果体部髄膜腫 : 症例報告および文献的考察
- モヤモヤ病症例に対するSTA-MCA吻合術後の追跡脳血管写所見
- 60. アルブミン投与によるsymptomatic vasospasmの予防
- 早期手術適応外の高度クモ膜下出血例に対するアルブミン療法
- 遅発性脳虚血に対する対策:-高度のクモ膜下出血に対する早期手術とアルブミン療法の併用-
- いわゆるモヤモヤ病症例に対するSTA-MCA anastomosis
- STA-MCA吻合術により著効を奏した小児中大脳動脈閉塞症の1例